Literature DB >> 16897174

Ganglioside GD1a regulation of caveolin-1 and Stim1 expression in mouse FBJ cells: augmented expression of caveolin-1 and Stim1 in cells with increased GD1a content.

Li Wang1, Shizuka Takaku, Pu Wang, Dan Hu, Sumiko Hyuga, Toshinori Sato, Sadako Yamagata, Tatsuya Yamagata.   

Abstract

GD1a was previously shown responsible for regulating cell motility, cellular adhesiveness to vitronectin, phosphorylation of c-Met and metastatic ability of mouse FBJ osteosarcoma cells. To determine the particular molecules regulated by GD1a, FBJ cells were assessed for tumor-related gene expression by semi-quantitative RT-PCR. Caveolin-1 and stromal interaction molecule 1 (Stim1) expression in FBJ-S1 cells, rich in GD1a, were found to be 6 and 4 times as much, respectively, than in FBJ-LL cells devoid of GD1a. Enhanced production of caveolin-1 in protein was confirmed by Western blotting. A low-metastatic FBJ-LL cell variant, having high GD1a expression through beta1-4GalNAcT-1 (GM2/GD2 synthase) cDNA transfection (Hyuga S, et al, Int J Cancer 83: 685-91, 1999), showed enhanced production of caveolin-1 and Stim1 in mRNA and protein, compared to mock-transfectant M5. Incubation of FBJ-M5 cells with exogenous GD1a augmented the expression of caveolin-1 in mRNA and protein and Stim1 in mRNA as well. Treatment of FBJ-S1 with fumonisin B1, an inhibitor of N-acylsphinganine synthesis, for 15 days caused the complete depletion of gangliosides and suppressed the expression of caveolin-1 and Stim1. St3gal5 siRNA transfected cells showed decreased expression of caveolin-1 and Stim1 mRNA, as well as St3gal5 mRNA. These findings clearly indicate ganglioside GD1a to be involved in the regulation of the transformation suppressor genes, caveolin-1 and Stim1. Moreover, treatment with GD1a of mouse melanoma B16 cells and human hepatoma HepG2 cells brought about elevated expression of caveolin-1 and Stim1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897174     DOI: 10.1007/s10719-006-5742-3

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  54 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Caveolins: structure and function in signal transduction.

Authors:  Wanda M Krajewska; Izabela Masłowska
Journal:  Cell Mol Biol Lett       Date:  2004       Impact factor: 5.787

Review 3.  Caveolae and caveolins.

Authors:  R G Parton
Journal:  Curr Opin Cell Biol       Date:  1996-08       Impact factor: 8.382

Review 4.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

5.  Caveolin-1 and caveolin-2 expression in mouse macrophages. High density lipoprotein 3-stimulated secretion and a lack of significant subcellular co-localization.

Authors:  P Gargalovic; L Dory
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

6.  Reduction of caveolin and caveolae in oncogenically transformed cells.

Authors:  A J Koleske; D Baltimore; M P Lisanti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells.

Authors:  S W Lee; C L Reimer; P Oh; D B Campbell; J E Schnitzer
Journal:  Oncogene       Date:  1998-03       Impact factor: 9.867

8.  Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling.

Authors:  K Iwabuchi; K Handa; S Hakomori
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

9.  STIM1, an essential and conserved component of store-operated Ca2+ channel function.

Authors:  Jack Roos; Paul J DiGregorio; Andriy V Yeromin; Kari Ohlsen; Maria Lioudyno; Shenyuan Zhang; Olga Safrina; J Ashot Kozak; Steven L Wagner; Michael D Cahalan; Gönül Veliçelebi; Kenneth A Stauderman
Journal:  J Cell Biol       Date:  2005-05-02       Impact factor: 10.539

10.  Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton.

Authors:  J R Glenney; L Zokas
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

View more
  6 in total

Review 1.  Sphingolipids and expression regulation of genes in cancer.

Authors:  Gauri A Patwardhan; Yong-Yu Liu
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

2.  A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells.

Authors:  Alessandro Prinetti; Ting Cao; Giuditta Illuzzi; Simona Prioni; Massimo Aureli; Nicoletta Gagliano; Giovanni Tredici; Virginia Rodriguez-Menendez; Vanna Chigorno; Sandro Sonnino
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

3.  Involvement of Ext1 and heparanase in migration of mouse FBJ osteosarcoma cells.

Authors:  Yinan Wang; XiaoYan Yang; Sadako Yamagata; Tatsuya Yamagata; Toshinori Sato
Journal:  Mol Cell Biochem       Date:  2012-10-10       Impact factor: 3.396

4.  Ganglioside deficiency in hypothalamic POMC neurons promotes body weight gain.

Authors:  V Dieterle; S Herzer; H-J Gröne; R Jennemann; V Nordström
Journal:  Int J Obes (Lond)       Date:  2019-06-05       Impact factor: 5.095

Review 5.  Sphingolipids and Lymphomas: A Double-Edged Sword.

Authors:  Alfredo Pherez-Farah; Rosa Del Carmen López-Sánchez; Luis Mario Villela-Martínez; Rocío Ortiz-López; Brady E Beltrán; José Ascención Hernández-Hernández
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

6.  Lipid microdomain modification sustains neuronal viability in models of Alzheimer's disease.

Authors:  Silke Herzer; Sascha Meldner; Klara Rehder; Hermann-Josef Gröne; Viola Nordström
Journal:  Acta Neuropathol Commun       Date:  2016-09-17       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.